214 related articles for article (PubMed ID: 5289422)
21. L-Asparagine synthetase in serum as a marker for neoplasia.
Cooney DA; King VD; Cable RG; Taylor B; Wodinsky I
Cancer Res; 1976 Sep; 36(9 pt.1):3238-45. PubMed ID: 10081
[TBL] [Abstract][Full Text] [Related]
22. Determinants of responsiveness to 5-fluorouridine in transplantable murine leukemias.
Kessel D; Bruns R; Hall TC
Mol Pharmacol; 1971 Mar; 7(2):117-21. PubMed ID: 4256648
[No Abstract] [Full Text] [Related]
23. [Cellular test system for studying the biological properties of preparations with L-asparaginase activity].
Kondrat'eva NA; Dobrynin IaV; Merkulov MF
Antibiotiki; 1977 Nov; 22(11):994-8. PubMed ID: 596848
[TBL] [Abstract][Full Text] [Related]
24. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.
Capizzi RL
Cancer Treat Rep; 1981; 65 Suppl 4():115-21. PubMed ID: 7049375
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of glycoprotein synthesis in L5178Y mouse leukaemic cells by L-asparaginase in vitro.
Bosmann HB; Kessel D
Nature; 1970 May; 226(5248):850-1. PubMed ID: 5444625
[No Abstract] [Full Text] [Related]
26. A comparison of 4-amino-4-deoxy-N10-methylpteroic acid and methotrexate transport by mouse leukemia cells.
Kessel D
Mol Pharmacol; 1969 Jan; 5(1):21-5. PubMed ID: 5392912
[No Abstract] [Full Text] [Related]
27. Detection of endotoxin in commercial L-asparaginase preparations by complement fixation and separation by chromatography.
Loos M; Vadlamudi S; Meltzer M; Shifrin S; Borsos T; Goldin A
Cancer Res; 1972 Nov; 32(11):2292-6. PubMed ID: 4563138
[No Abstract] [Full Text] [Related]
28. Effects of perfusion with amethopterin on L1210 leukemia cells in spin filter culture.
Thayer PS; Himmelfarb P; Roberts D
Cancer Res; 1970 Jun; 30(6):1709-14. PubMed ID: 5457937
[No Abstract] [Full Text] [Related]
29. The intrinsic glutaminase activity of asparaginase: cytotoxicity and cellular resistance.
Hakimi J; Bosmann HB
Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):581-95. PubMed ID: 523789
[No Abstract] [Full Text] [Related]
30. Experimental studies with L-asparaginase in mouse leukemias.
Burchenal JH; Benvenisti D; Dollinger M
Recent Results Cancer Res; 1970; 33():102-13. PubMed ID: 5292716
[No Abstract] [Full Text] [Related]
31. L-asparaginase-induced alterations of Burkitt's lymphoma cells.
Perez-Bercoff R; Carrara G; Cioé L; Rita G; Caputo A; Castelli L
J Natl Cancer Inst; 1973 Apr; 50(4):833-40. PubMed ID: 4350026
[No Abstract] [Full Text] [Related]
32. Influence of a benign virus upon mouse leukemia during asparaginase therapy.
Riley V
Pathol Biol (Paris); 1970; 18(15):757-64. PubMed ID: 4917552
[No Abstract] [Full Text] [Related]
33. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
Chabner BA; Chello PL; Bertino JR
Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
[No Abstract] [Full Text] [Related]
34. Amino acid content of L5178Y and L5178Y/L-ASE cells after L-asparaginase treatment.
Keefer JF; Moraga DA; Schuster SM
Biochem Med; 1985 Oct; 34(2):135-50. PubMed ID: 4084239
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity to L-asparaginase and amino acid metabolism.
Miller HK; Krakoff IH; Salser JS; Balis ME
J Natl Cancer Inst; 1970 May; 44(5):1129-39. PubMed ID: 5514473
[No Abstract] [Full Text] [Related]
36. Sites of action of amethopterin: intrinsic and acquired drug resistance.
Harrap KR; Hill BT; Furness ME; Hart LI
Ann N Y Acad Sci; 1971 Nov; 186():312-24. PubMed ID: 5289423
[No Abstract] [Full Text] [Related]
37. Inhibition of membrane transport of 5-fluoro[6-3H]deoxyuridine into L5178Y mouse leukemia cells.
Wigler PW; Schluter DN
Cancer Res; 1976 Sep; 36(9 pt.1):3207-11. PubMed ID: 135641
[TBL] [Abstract][Full Text] [Related]
38. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
Schwartz SA; Morgenstern B; Capizzi RL
Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
[TBL] [Abstract][Full Text] [Related]
39. Survival of tumor-bearing mice exposed to heavy water or heavy water plus methotrexate.
Laissue JA; Bürki H; Berchtold W
Cancer Res; 1982 Mar; 42(3):1125-9. PubMed ID: 6800646
[TBL] [Abstract][Full Text] [Related]
40. Factors influencing the therapeutic activity of L-asparaginase (NSC 109229) in leukemic (L5178Y) mice.
Vadlamudi S; Padarathsingh M; Waravdekar VS; Goldin A
Cancer Res; 1970 May; 30(5):1467-72. PubMed ID: 5426950
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
